Design and biological evaluation of novel antioxidants containing N-t-Butyl-N-hydroxylaminophenyl moieties

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 14, 2003, Pages 2273-2275

  Kim, Kyung Mi ^a   Kim, Kyung Hwa ^b   Kang, Tae Cheon ^c   Kim, Won Yeon ^d   Lee, Myung Ryul ^a   Jung, Hyuk Jun ^b   Hwang, In Koo ^c   Ko, Sung Bo ^b   Koh, Jae Young ^d   Won, Moo Ho ^c   Oh, Eu Gene ^b   Shin, Injae ^a  

^a Yonsei University   (South Korea)

^b Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^c Hallym University   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BENZENE DERIVATIVE; EBSELEN; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; GERBIL; IN VITRO STUDY; IN VIVO STUDY; NEUROPROTECTION; NONHUMAN; SINGLE DRUG DOSE;

EID: 12444312571     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00444-X     Document Type: Article

References (17)

1. (a). For reviews, Halliwell B. J. Neurochem. 59:1992;1609
2. (a). For reviews, Halliwell B. J. Neurochem. 59:1992;1609 (b) Halliwell B. FASEB J. 1:1987;1358.
3. Evans P.H. Brit. Med. Bull. 49:1993;577.
4. Marciniak G., Petty M.A. Drugs Future. 21:1996;1037.
5. (a) Chabrier P.-E., Auguet M., Spinnewyn B., Auvin S., Cornet S., Demerlé-Pallardy C., Guilmard-Favre C., Marin J.-G., Pignol B., Gillard-Roubert V., Roussillot-Charnet C., Schulz J., Viossat I., Bigg D., Moncada S. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10824 (b) Jarrott B., Callaway J.K., Jackson W.R., Beart P.M. Drug Develop. Res. 46:1999;261 (c) Annoura H., Nakanishi K., Toba T., Takemoto N., Imajo S., Miyajima A., Tamura-Horikawa Y., Tamura S. J. Med. Chem. 43:2000;3372.
6. (b) Jarrott B., Callaway J.K., Jackson W.R., Beart P.M. Drug Develop. Res. 46:1999;261 (c) Annoura H., Nakanishi K., Toba T., Takemoto N., Imajo S., Miyajima A., Tamura-Horikawa Y., Tamura S. J. Med. Chem. 43:2000;3372.
7. (a) Chabrier P.-E., Auguet M., Spinnewyn B., Auvin S., Cornet S., Demerlé-Pallardy C., Guilmard-Favre C., Marin J.-G., Pignol B., Gillard-Roubert V., Roussillot-Charnet C., Schulz J., Viossat I., Bigg D., Moncada S. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10824 (b) Jarrott B., Callaway J.K., Jackson W.R., Beart P.M. Drug Develop. Res. 46:1999;261 (c) Annoura H., Nakanishi K., Toba T., Takemoto N., Imajo S., Miyajima A., Tamura-Horikawa Y., Tamura S. J. Med. Chem. 43:2000;3372.
8. (a) Inoue K., Hayamizu T., Iwamura H., Hashizume D., Ohashi Y. J. Am. Chem. Soc. 118:1996;1803 (b) Shultz D.A., Farmer G.T. J. Org. Chem. 63:1998;6254.
9. (a) Inoue K., Hayamizu T., Iwamura H., Hashizume D., Ohashi Y. J. Am. Chem. Soc. 118:1996;1803 (b) Shultz D.A., Farmer G.T. J. Org. Chem. 63:1998;6254.
10. Shultz D.A., Gwaltney K.P., Lee H. J. Org. Chem. 63:1998;769.
11. Thomas C.E., Ohlweiler D.F., Carr A.A., Nieduzak T.R., Hay D.A., Adams G., Vaz R., Bernotas R.C. J. Biol. Chem. 271:1996;3097.
12. Back T.G., Dyck B.P. J. Am. Chem. Soc. 119:1997;2097. and references are therein.
13. Watanabe A., Noguchi N., Fujisawa A., Kodama T., Tamura K., Cynshi O., Niki E. J. Am. Chem. Soc. 122:2000;5438.
14. Lee J.-Y., Kim Y., Hee Koh J.-Y. J. Neurosci. 21:2001;RC171.
15. (a) Kang T.C., Park S.K., Hwang I.K., An S.J., Choi S.Y., Cho S.W., Won M.H. Brain Res. 944:2002;10
16. (a) Kang T.C., Park S.K., Hwang I.K., An S.J., Choi S.Y., Cho S.W., Won M.H. Brain Res. 944:2002;10 (b) Wie M.B., Won M.H., Lee K.H., Shin J.H., Lee J.C., Suh H.W., Song D.J., Kim Y.H. Neurosci. Lett. 225:1997;93.
17. Twenty gerbils were treated with a single dose (60 mg/kg gerbil) of compound 3 prior and posterior to ischemic injury.